This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis - XML Representation
Raw xml | Download
<EvidenceVariable xmlns="http://hl7.org/fhir">
<id value="179784"/>
<meta>
<versionId value="3"/>
<lastUpdated value="2023-12-01T22:26:01.820Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: EvidenceVariable</b><a name="179784"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource EvidenceVariable "179784" Version "3" Updated "2023-12-01 22:26:01+0000" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-group-assignment.html">GroupAssignment</a></p></div><p><b>EvidenceVariableDefinition</b>: Defined in handling and category elements <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-handling-and-category)</span></p><p><b>StructureDefinition Work Group</b>: cds</p><p><b>url</b>: <code>https://fevir.net/resources/EvidenceVariable/179784</code></p><p><b>identifier</b>: FEvIR Object Identifier: 179784</p><p><b>version</b>: 1.0.0-ballot</p><p><b>name</b>: Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis</p><p><b>title</b>: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis</p><p><b>status</b>: active</p><p><b>date</b>: 2023-12-17 16:55:23+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19</p><h3>UseContexts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td>Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication')</td><td>group-assignment <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td></tr></table><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style="display: none">*</td><td>cite-as</td><td>GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.</td></tr></table><p><b>handling</b>: dichotomous</p><blockquote><p><b>category</b></p><p><b>EvidenceVariableCategoryValueReference</b>: <a href="Group-179786.html">Group/179786: ExposureDefinition: Therapeutic-dose anticoagulation with heparin</a> "ExposureDefinition_Therapeutic_dose_anticoagulation_with_heparin"</p><p><b>name</b>: Therapeutic-dose anticoagulation with heparin</p></blockquote><blockquote><p><b>category</b></p><p><b>EvidenceVariableCategoryValueReference</b>: <a href="Group-179785.html">Group/179785: ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis</a> "ComparatorDefinition_Usual_care_pharmacologic_thromboprophylaxis"</p><p><b>name</b>: Usual-care pharmacologic thromboprophylaxis</p></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-definition">
<valueCodeableReference>
<concept>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-handling-and-category"/>
<display value="Defined in handling and category elements"/>
</coding>
</concept>
</valueCodeableReference>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="cds"/>
</extension>
<url value="https://fevir.net/resources/EvidenceVariable/179784"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="179784"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<version value="1.0.0-ballot"/>
<name
value="Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis"/>
<title
value="GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis"/>
<status value="active"/>
<date value="2023-12-17T16:55:23+00:00"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19"/>
<useContext>
<code>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="evidence-communication"/>
<display value="Evidence Communication"/>
</code>
<valueCodeableConcept>
<text value="group-assignment"/>
</valueCodeableConcept>
</useContext>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<relatedArtifact>
<type value="cite-as"/>
<citation
value="GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784."/>
</relatedArtifact>
<handling value="dichotomous"/>
<category>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-category-value-reference">
<valueReference>🔗
<reference value="Group/179786"/>
<type value="Group"/>
<display
value="ExposureDefinition: Therapeutic-dose anticoagulation with heparin"/>
</valueReference>
</extension>
<name value="Therapeutic-dose anticoagulation with heparin"/>
</category>
<category>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-category-value-reference">
<valueReference>🔗
<reference value="Group/179785"/>
<type value="Group"/>
<display
value="ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis"/>
</valueReference>
</extension>
<name value="Usual-care pharmacologic thromboprophylaxis"/>
</category>
</EvidenceVariable>
|
Propose a change